TransThera Biosciences Co., Ltd Report issue

For profit Phase 1 Phase 2
Founded: Nanjing China (2016)

Organization Overview

First Clinical Trial
2018
NCT03654547
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TransThera Biosciences Co., Ltd | TransThera Sciences (Nanjing), Inc.